Search Results - "Zarbo, Roberto Ignazio"
-
1
Inflammation, Infectious Triggers, and Parkinson's Disease
Published in Frontiers in neurology (19-02-2019)“…Parkinson's disease is a neurodegenerative disorder characterized by progressive loss of dopaminergic neurons of the substantia nigra pars compacta with a…”
Get full text
Journal Article -
2
Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis
Published in International journal of molecular sciences (28-12-2023)“…Myasthenia gravis is an antibody-mediated autoimmune neurological disorder characterized by impaired neuromuscular junction transmission, resulting in muscle…”
Get full text
Journal Article -
3
Effect of Different Disease-Modifying Therapies on Humoral Response to BNT162b2 Vaccine in Sardinian Multiple Sclerosis Patients
Published in Frontiers in immunology (09-12-2021)“…Vaccination against COVID-19 is highly recommended to patients affected by multiple sclerosis (MS); however, the impact of MS disease-modifying therapies…”
Get full text
Journal Article -
4
TDP-43 and HERV-K Envelope-Specific Immunogenic Epitopes Are Recognized in ALS Patients
Published in Viruses (18-11-2021)“…The human endogenous retrovirus-K (HERV-K) and TAR DNA-binding protein 43 (TDP-43) have been associated with the pathophysiology of amyotrophic lateral…”
Get full text
Journal Article -
5
Identification of hsa_circ_0018905 as a New Potential Biomarker for Multiple Sclerosis
Published in Cells (Basel, Switzerland) (09-10-2024)“…Multiple sclerosis (MS) is a demyelinating autoimmune disease characterized by early onset, for which the interaction of genetic and environmental factors is…”
Get full text
Journal Article -
6
Cross-sectional analysis of the humoral response after SARS-CoV-2 vaccination in Sardinian multiple sclerosis patients, a follow-up study
Published in Frontiers in immunology (18-08-2022)“…Monitoring immune responses to SARS-CoV-2 vaccination and its clinical efficacy over time in Multiple Sclerosis (MS) patients treated with disease-modifying…”
Get full text
Journal Article -
7
Antihuman Endogenous Retrovirus Immune Response and Adaptive Dysfunction in Autism
Published in Biomedicines (09-06-2022)“…ASD is a neurodevelopmental disorder of unknown aetiology but with a known contribution of pathogenic immune-mediated mechanisms. HERVs are associated with…”
Get full text
Journal Article -
8
Rasagiline Withdrawal Syndrome in Parkinson's Disease
Published in Brain sciences (05-02-2022)“…Parkinson's disease (PD) patients using dopamine agonists can develop withdrawal symptoms, referred to as dopamine agonist withdrawal syndrome (DAWS), under…”
Get full text
Journal Article -
9
An innovative training program based on virtual reality and treadmill: effects on gait of persons with multiple sclerosis
Published in Disability and rehabilitation (17-07-2017)“…Aim: In this single blind randomized controlled trial, we examined the effect of a virtual reality-based training on gait of people with multiple sclerosis…”
Get full text
Journal Article -
10
Determinants of self-perceived quality of life in mildly disabled multiple sclerosis patients: a cross-sectional study
Published in Journal of neurology (01-06-2024)“…Introduction While the determinants influencing self-perceived health-related quality of life (spHRQoL) in persons with multiple sclerosis (pwMS) and severe…”
Get full text
Journal Article -
11
RNA‐binding proteins in autoimmunity: From genetics to molecular biology
Published in Wiley interdisciplinary reviews. RNA (01-07-2023)“…Autoimmune diseases (ADs) are chronic pathologies generated by the loss of immune tolerance to the body's own cells and tissues. There is growing recognition…”
Get full text
Journal Article -
12
On a 5-year-old girl with multiple sclerosis treated with natalizumab
Published in Neurological sciences (01-08-2023)Get full text
Journal Article -
13
Personality traits predict perceived health-related quality of life in persons with multiple sclerosis
Published in Multiple sclerosis (01-04-2016)“…Background: Personality traits can affect health-related quality of life (HRQoL) in different disorders. In multiple sclerosis (MS), personality traits can…”
Get full text
Journal Article -
14
Long‐term trajectory of acquired demyelinating syndrome and multiple sclerosis in children
Published in Developmental medicine and child neurology (01-09-2021)“…Aim We assessed the frequency, characteristics, and future trajectory of monophasic acquired demyelinating syndromes (ADS) associated with conversion to…”
Get full text
Journal Article -
15
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study
Published in Neurology (28-11-2017)“…OBJECTIVE:To assess whether the presence of concomitant diseases at multiple sclerosis (MS) diagnosis is associated with the choice and the treatment…”
Get full text
Journal Article -
16
The role of ethnicity and native-country income in multiple sclerosis: the Italian multicentre study (MS-MigIT)
Published in Journal of neurology (01-05-2024)“…Objective Multiple sclerosis (MS) is a complex disorder in which environmental and genetic factors interact modifying disease risk and course. This…”
Get full text
Journal Article -
17
Risk of disease relapse, safety and tolerability of SARS‐CoV‐2 vaccination in patients with chronic inflammatory neuropathies
Published in European journal of neurology (01-07-2023)“…Background and purpose The aim was to evaluate the risk of relapse after severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccination, and its…”
Get full text
Journal Article -
18
Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination
Published in Frontiers in immunology (15-07-2024)“…Disease-modifying therapies (DMTs) have been shown to improve disease outcomes in multiple sclerosis (MS) patients. They may also impair the immune response to…”
Get full text
Journal Article -
19
Cladribine vs other drugs in MS: Merging randomized trial with real-life data
Published in Neurology : neuroimmunology & neuroinflammation (01-11-2020)“…OBJECTIVECladribine tablets were tested against placebo in randomized controlled trials (RCTs). In this study, the effectiveness of cladribine vs other…”
Get full text
Journal Article -
20
Switch Strategies in RRMS: A Real-Life Multi Center Study (S24.003)
Published in Neurology (05-04-2016)“…Abstract only…”
Get full text
Journal Article